Search References Drug Actions/Targets About Access data Feedback
Sign In
mitontu@gmail.com
2021 MitoTox | (CC BY-NC 4.0)
Drug

D1358 | Urolithin A

Molecular Formula C13H8O4
Molecular Weight 228.2
Structure
Description metabolite compound resulting from the transformation of ellagitannins by the gut bacteria; benzo-coumarins or dibenzo-alpha-pyrones

Toxicity Dose Time Species Model Method Action Positive criterion Reference
MITOPHAGY enhance 248


  • 1143-70-0 2-Biphenylcarboxylic acid, 2',4,4'-trihydroxy-, delta-lactone 3,8-Dihydroxy-6H-dibenzo(b,d)pyran-6-one
    3,8-Dihydroxyurolithin 3,8-Hydroxydibenzo-alpha-pyrone 3,8-dihydroxy-6H-benzo[c]chromen-6-one
    3,8-dihydroxy-6h-dibenzo[b,d]pyran-6-one 3,8-dihydroxy-urolithin 3,8-dihydroxybenzo[c]chromen-6-one
    6H-Dibenzo(b,d)pyran-6-one, 3,8-dihydroxy- 6H-Dibenzo[b,d]pyran-6-one, 3,8-dihydroxy- 6H-Dibenzo[b,d]pyran-6-one,3,8-dihydroxy-
    AK544544 AKOS028108778 CCG-266776
    CHEMBL1836264 CS-6305 CTK4A8707
    DB-122496 DB15464 DS-19328
    DTXSID40150694 FT-0778244 HY-100599
    J-003086 KS-00000TQI Q15634120
    SCHEMBL803408 Urolithin A, >=97% (HPLC) ZINC13484727
    s5312 urolithin A

    DrugBank DB15464
    CAS Number 1143-70-0
    PubChem Compound 5488186